查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2045999

臍帶血庫服務市場 - 全球產業規模、佔有率、趨勢、機會、預測：儲存服務、組成部分、應用、最終用戶、地區和競爭格局，2021-2031年

Cord Blood Bank Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Storage Services, By Component, By Application, By End-User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球臍帶血庫服務市場預計將從 2025 年的 351.1 億美元大幅成長至 2031 年的 513.2 億美元，複合年成長率為 6.53%。

這些服務專門從事從臍帶血和胎盤中採集造血幹細胞的收集、處理和冷凍保存，以備未來醫療應用。這個市場主要透過兩種模式運作：“私人庫”，即家庭付費保存幹細胞以備將來之需；以及“公共庫”，即促進向需要移植的非親緣患者進行利他捐贈。推動市場成長的根本原因是骨髓惡性腫瘤和需要幹細胞治療的免疫系統疾病發生率不斷上升。此外，隨著父母對臍帶血的生物學優勢（例如與其他幹細胞來源相比，移植物抗宿主疾病風險較低）的認知不斷加深，全球對這些保存設施的需求也持續成長。

市場概覽
預測期 2027-2031
市場規模：2025年 351.1億美元
市場規模：2031年 513.2億美元
複合年成長率：2026-2031年 6.53%
成長最快的細分市場 私人臍帶血庫
最大的市場 北美洲

然而，由於臨床上優先採用單倍體相合骨髓移植（其植入速度更快、成本效益更高），臍帶血儲存領域面臨巨大的挑戰。這導致儲存臍帶血的利用率下降。這種競爭威脅著臍帶血庫的財務生存，因為儘管捐獻率停滯不前，它們仍必須維持昂貴的低溫儲存基礎設施。為了滿足這些醫療需求，世界骨髓捐贈者協會報告稱，到2026年，其全球搜尋和配型服務將登記755,011份臍帶血。如此龐大的數字凸顯了在不斷變化的治療格局下，該行業強大的營運能力。

市場促進因素

造血幹細胞臨床應用的不斷拓展正從根本上改變著臍帶血庫產業，使其應用範圍從傳統的腫瘤治療擴展到先進的細胞療法。這項進展的顯著特徵是監管方面的重大里程碑，這些里程碑確認了臍帶血作為治療嚴重非惡性疾病的有效來源，從而提高了儲存臍帶血的效用。其中一個主要進展是細胞療法監管的擴展，例如美國食品藥物管理局（FDA）於2025年12月核准了Omishilji療法。這是首個核准治療無法找到合適捐贈者的重型再生障礙性貧血患者的造血幹細胞移植療法，擴大了合格患者群體，並進一步提升了臍帶血庫治療對醫療專業人員和未來客戶的價值。

同時，策略性市場擴張和企業投資是推動產業發展的關鍵因素，領導企業正透過多元化服務組合來確保長期的財務永續性。為了應對競爭壓力，私人銀行正在加快資源配置，拓展至新的服務領域，並進入先前未開發的地區，以期獲得更大的市場佔有率。例如，FamiCord集團2025年4月發布的年度報告詳細闡述了其計劃在該會計年度內在包括奧地利在內的其他歐洲市場推出胎盤庫服務。根據Cells4Life預測，到2025年，全球將進行超過6萬例臍帶血移植手術，這些策略性舉措對於在日趨成熟的市場中維持成長至關重要。這凸顯了這種生物資源在醫療保健領域持續的重要性。

市場挑戰

全球臍帶血庫服務市場正受到臨床治療策略到單倍體相合骨髓移植優先發展的顯著影響。這種替代療法具有許多優勢，包括能夠快速獲得親屬捐贈者以及嗜中性白血球植入速度更快，從而降低移植後併發症和整體醫療成本。因此，移植中心越來越傾向於優先選擇這些部分相合的供體，而非儲存的臍帶血，這直接導致臍帶血儲存服務的市場佔有率萎縮。

使用率的下降正使臍帶血庫面臨岌岌可危的財務困境。這些機構需要承擔巨額的固定成本來維護低溫儲存基礎設施，以儲存其龐大的庫存，而用於治療目的的臍帶血收入卻在同步減少。這種利用率的巨大差異在近期的行業數據中得到了清晰的體現。根據國際血液和骨髓移植研究中心（CIBMTR）的數據，預計到2025年，臍帶血僅佔同種異體移植供體來源的3%，而單倍體相合供體將佔到21%。這種日益擴大的差距凸顯了臍帶血庫在不斷變化的醫療標準下，如何實現資產變現所面臨的巨大營運和財務挑戰。

市場趨勢

以策略性併購為主導的產業重組正在積極重塑全球臍帶血庫服務市場。各公司力求透過規模經濟降低高昂的固定營運成本。在一個競爭激烈、監管要求嚴格的成熟市場中，大型企業正積極進行策略性收購，收購規模小規模的臍帶血庫。此舉旨在最佳化低溫儲存基礎設施，擴大基本客群，集中處理能力，並最終降低單位儲存成本，確保企業在市場波動中實現長期永續性。 Cryo-Cell International 公司2025年2月公佈的合併銷售額達3,200萬美元，充分展現了透過此類策略定位所能獲得的雄厚財務實力，凸顯了其強大的資本基礎，這對於在日益整合的市場格局中保持市場領先地位至關重要。

同時，結合公共和私人資產保全方案的混合銀行模式正逐漸成為應對傳統私人銀行面臨的資產利用率挑戰的關鍵策略。透過整合私人家族資產保全和公共捐贈機會，以及合約開發與製造組織（CDMO）服務，銀行正在建立多元化的收入結構，從而降低對停滯不前的資產釋放率的依賴。這種多元化的方法不僅滿足了利他主義的醫療保健需求，也確保了跨多個服務領域的持續產生收入，並有效緩解了因維持低利用率的大量庫存而帶來的財務壓力。 FamiCord集團已清楚證明了這種模式的經濟效益。該集團公佈的2025年4月初步EBITDA為880萬歐元，這一數字凸顯了多元化混合銀行業務相比於獨立的私人銀行模式所具有的更強的財務韌性。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球臍帶血庫服務市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依儲存服務（公共臍帶血庫、私人臍帶血庫、混合臍帶血庫）
    • 依成分分類（臍帶血、臍帶組織、胎盤、其他）
    • 依應用領域（癌症、血液疾病、代謝失調、骨質疏鬆症、免疫力缺乏疾病、骨髓衰竭症候群）
    • 依最終使用者（醫院/專科診所、研究機構、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美臍帶血庫服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲臍帶血庫服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區臍帶血庫服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲臍帶血庫服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲臍帶血庫服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球臍帶血庫服務市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • BR Systems Inc.
  • China Cord Blood Corporation
  • Americord Registry LLC
  • Cordlife Sciences India Pvt. Ltd.
  • Cryo-Cell International Inc.
  • CSG-BIO
  • Vita 34, Inc.
  • CordVida
  • ViaCord Inc.
  • Virgin Health Bank

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 17469

The Global Cord Blood Bank Services Market is projected to expand significantly, growing from USD 35.11 Billion in 2025 to USD 51.32 Billion by 2031, at a Compound Annual Growth Rate of 6.53%. These services specialize in the collection, processing, and cryogenic preservation of hematopoietic stem cells sourced from the umbilical cord and placenta, intended for future medical use. The market primarily operates through two models: private banking, where families pay for storage for their own potential needs, and public banking, which facilitates altruistic donations for unrelated patients requiring transplants. Fundamental market growth is driven by the increasing incidence of hematological malignancies and immune disorders that necessitate stem cell interventions. Additionally, growing parental understanding of cord blood's biological advantages, such as a reduced risk of graft-versus-host disease compared to alternative stem cell sources, continuously fuels global demand for these preservation facilities.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 35.11 Billion
Market Size 2031USD 51.32 Billion
CAGR 2026-20316.53%
Fastest Growing SegmentPrivate Cord Blood Banks
Largest MarketNorth America

However, the sector faces a considerable hurdle due to a clinical shift favoring haploidentical bone marrow transplants, which often offer quicker engraftment and are more cost-effective, thereby affecting the utilization rates of stored cord blood. This competitive pressure poses a threat to the financial viability of banks, which must sustain expensive cryogenic infrastructure despite static release rates. Illustrating the current substantial inventory available to meet these medical demands, the World Marrow Donor Association reported 755,011 cord blood units listed in its global Search & Match Service in 2026. This considerable figure underscores the industry's immense operational capacity amid these evolving therapeutic landscapes.

Market Driver

Expanding clinical applications for hematopoietic stem cells are profoundly reshaping the cord blood banking sector, pushing its scope beyond traditional oncology treatments into advanced cell therapies. This progression is marked by significant regulatory milestones that affirm cord blood as a viable source for treating severe non-malignant conditions, thereby enhancing the utility of stored units. A key development was the regulatory expansion for cellular therapies, as exemplified by the U.S. Food and Drug Administration's approval of Omisirge in December 2025. This marked the first hematopoietic stem cell transplant therapy for patients with severe aplastic anemia lacking a compatible donor, thereby broadening the eligible patient population and reinforcing cord blood banking's therapeutic value to healthcare providers and prospective clients.

Simultaneously, strategic market expansion and corporate investments are crucial drivers propelling the industry forward as major players diversify their service portfolios to ensure long-term financial viability. In response to competitive pressures, private banks are increasingly allocating resources towards new service lines and penetrating previously untapped geographic regions to secure a larger market share. For instance, FamiCord Group's April 2025 Annual Report detailed plans to launch placenta banking services in additional European markets, including Austria, within the fiscal year. These strategic initiatives are vital for sustaining growth within a maturing market, with over 60,000 cord blood transplants performed worldwide by 2025, according to Cells4Life, underscoring the enduring medical relevance of this biological resource.

Market Challenge

The Global Cord Blood Bank Services Market is significantly hampered by an ongoing clinical transition favoring haploidentical bone marrow transplants. This alternative therapeutic approach offers distinct advantages, including the quick availability of family donors and more rapid neutrophil engraftment, which collectively lead to fewer post-transplant complications and lower overall healthcare expenses. Consequently, transplant centers are increasingly prioritizing these partially matched donors over stored cord blood units, directly diminishing the market share for cord blood preservation services.

This reduction in utilization creates a precarious financial situation for cord blood banks. While these facilities bear substantial fixed costs for maintaining cryogenic infrastructure to house extensive inventories, the revenue generated from releasing units for therapeutic use is concurrently decreasing. The stark difference in adoption is clearly reflected in recent industry data: according to the Center for International Blood and Marrow Transplant Research, in 2025, umbilical cord blood constituted merely 3% of donor sources for allogeneic transplants, whereas haploidentical donors accounted for a significant 21% share. This widening disparity highlights the considerable operational and financial difficulties banks encounter in monetizing their assets amidst evolving medical standards.

Market Trends

Industry consolidation, primarily driven by strategic mergers and acquisitions, is actively reshaping the Global Cord Blood Bank Services Market as companies strive to mitigate high fixed operational costs through economies of scale. Within a maturing market characterized by intense competitive pricing and stringent regulatory demands, larger entities are strategically acquiring smaller banks. This strategy aims to optimize cryogenic infrastructure, expand their client base, centralize processing capabilities, and ultimately reduce per-unit preservation costs, thereby ensuring long-term sustainability against market volatility. Illustrating the financial strength achievable through such strategic positioning, Cryo-Cell International reported consolidated revenues of $32.0 million in February 2025, underscoring the robust capital foundation essential for maintaining market leadership in this consolidating landscape.

Concurrently, the adoption of hybrid banking models, which combine public and private storage options, is emerging as a crucial strategy to address the utilization challenges confronting traditional private banks. By integrating private family storage with public donation opportunities and Contract Development and Manufacturing Organization (CDMO) services, banks establish a diversified revenue structure that is less reliant on stagnant release rates. This multifaceted approach not only satisfies altruistic medical needs but also ensures continuous revenue generation across varied service lines, effectively counteracting the financial pressures associated with maintaining vast, underutilized inventories. The economic effectiveness of this model is clearly demonstrated by FamiCord Group, which reported a preliminary EBITDA of EUR 8.8 million in April 2025, a figure that emphasizes the superior financial resilience of diversified, hybrid banking operations compared to standalone private models.

Key Market Players

  • BR Systems Inc.
  • China Cord Blood Corporation
  • Americord Registry LLC
  • Cordlife Sciences India Pvt. Ltd.
  • Cryo-Cell International Inc.
  • CSG-BIO
  • Vita 34, Inc.
  • CordVida
  • ViaCord Inc.
  • Virgin Health Bank

Report Scope

In this report, the Global Cord Blood Bank Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cord Blood Bank Services Market, By Storage Services

  • Public Cord Blood Banks
  • Private Cord Blood Banks
  • Hybrid Cord Blood Banks

Cord Blood Bank Services Market, By Component

  • Cord Blood
  • Cord Tissue
  • Placenta
  • Others

Cord Blood Bank Services Market, By Application

  • Cancer
  • Blood Disorders
  • Metabolic Disorders
  • Osteoporosis
  • Immunodeficiency Disorders
  • Bone Marrow Failure Syndrome

Cord Blood Bank Services Market, By End-User

  • Hospitals & Specialty Clinics
  • Research Institutes
  • Others

Cord Blood Bank Services Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cord Blood Bank Services Market.

Available Customizations:

Global Cord Blood Bank Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cord Blood Bank Services Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Storage Services (Public Cord Blood Banks, Private Cord Blood Banks, Hybrid Cord Blood Banks)
    • 5.2.2. By Component (Cord Blood, Cord Tissue, Placenta, Others)
    • 5.2.3. By Application (Cancer, Blood Disorders, Metabolic Disorders, Osteoporosis, Immunodeficiency Disorders, Bone Marrow Failure Syndrome)
    • 5.2.4. By End-User (Hospitals & Specialty Clinics, Research Institutes, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Cord Blood Bank Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Storage Services
    • 6.2.2. By Component
    • 6.2.3. By Application
    • 6.2.4. By End-User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cord Blood Bank Services Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Storage Services
        • 6.3.1.2.2. By Component
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End-User
    • 6.3.2. Canada Cord Blood Bank Services Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Storage Services
        • 6.3.2.2.2. By Component
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End-User
    • 6.3.3. Mexico Cord Blood Bank Services Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Storage Services
        • 6.3.3.2.2. By Component
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End-User

7. Europe Cord Blood Bank Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Storage Services
    • 7.2.2. By Component
    • 7.2.3. By Application
    • 7.2.4. By End-User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cord Blood Bank Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Storage Services
        • 7.3.1.2.2. By Component
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End-User
    • 7.3.2. France Cord Blood Bank Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Storage Services
        • 7.3.2.2.2. By Component
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End-User
    • 7.3.3. United Kingdom Cord Blood Bank Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Storage Services
        • 7.3.3.2.2. By Component
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End-User
    • 7.3.4. Italy Cord Blood Bank Services Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Storage Services
        • 7.3.4.2.2. By Component
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End-User
    • 7.3.5. Spain Cord Blood Bank Services Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Storage Services
        • 7.3.5.2.2. By Component
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End-User

8. Asia Pacific Cord Blood Bank Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Storage Services
    • 8.2.2. By Component
    • 8.2.3. By Application
    • 8.2.4. By End-User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cord Blood Bank Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Storage Services
        • 8.3.1.2.2. By Component
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End-User
    • 8.3.2. India Cord Blood Bank Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Storage Services
        • 8.3.2.2.2. By Component
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End-User
    • 8.3.3. Japan Cord Blood Bank Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Storage Services
        • 8.3.3.2.2. By Component
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End-User
    • 8.3.4. South Korea Cord Blood Bank Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Storage Services
        • 8.3.4.2.2. By Component
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End-User
    • 8.3.5. Australia Cord Blood Bank Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Storage Services
        • 8.3.5.2.2. By Component
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End-User

9. Middle East & Africa Cord Blood Bank Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Storage Services
    • 9.2.2. By Component
    • 9.2.3. By Application
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cord Blood Bank Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Storage Services
        • 9.3.1.2.2. By Component
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End-User
    • 9.3.2. UAE Cord Blood Bank Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Storage Services
        • 9.3.2.2.2. By Component
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End-User
    • 9.3.3. South Africa Cord Blood Bank Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Storage Services
        • 9.3.3.2.2. By Component
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End-User

10. South America Cord Blood Bank Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Storage Services
    • 10.2.2. By Component
    • 10.2.3. By Application
    • 10.2.4. By End-User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cord Blood Bank Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Storage Services
        • 10.3.1.2.2. By Component
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End-User
    • 10.3.2. Colombia Cord Blood Bank Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Storage Services
        • 10.3.2.2.2. By Component
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End-User
    • 10.3.3. Argentina Cord Blood Bank Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Storage Services
        • 10.3.3.2.2. By Component
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cord Blood Bank Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. BR Systems Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. China Cord Blood Corporation
  • 15.3. Americord Registry LLC
  • 15.4. Cordlife Sciences India Pvt. Ltd.
  • 15.5. Cryo-Cell International Inc.
  • 15.6. CSG-BIO
  • 15.7. Vita 34, Inc.
  • 15.8. CordVida
  • 15.9. ViaCord Inc.
  • 15.10. Virgin Health Bank

16. Strategic Recommendations

17. About Us & Disclaimer